FDA Targets Clinics Offering Unapproved Stem Cell Therapies – Monthly Prescribing Reference
|
FDA Targets Clinics Offering Unapproved Stem Cell Therapies
Monthly Prescribing Reference HealthDay News — The US Food and Drug Administration has launched legal action to stop 2 stem cell clinics from providing unapproved treatments that have caused serious, long-term harm to some patients. On Wednesday, the FDA filed complaints in … |
